In a recent study on a mouse model of colorectal cancer, genetic ablation or pharmacological blockade of colony-stimulating factor 1 receptor (CSF1R)+ macrophages resulted in an increase in tumor-infiltrating Treg cells, limiting the antitumor activity of cytotoxic CD8+ T cell [4]. The gene discussed is CD8A; the disease is colorectal cancer.